Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control study Evgenij V Potapov, MD, Heinz R Zurbrügg,

Slides:

Advertisements

Similar presentations

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus

Advertisements

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Bloodless Surgery of Acute Type A Aortic Dissection in a Jehovah’s Witness Patient Miralem Pasic, MD, PhD, Wolfgang Ruisz, MD, Andreas Koster, MD, PhD,

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD

Beating heart operations including hybrid revascularization: initial experiences Friedrich-Christian Riess, MD, Joachim Schofer, MD, Peter Kremer, MD,

The Myocardial Protective Effects of a Moderate-Potassium Blood Cardioplegia in Pediatric Cardiac Surgery: A Randomized Controlled Trial Yang Liu, MD,

Wound-healing disturbances after vein harvesting for CABG: a randomized trial to compare the minimally invasive direct vision and traditional approaches

50th Anniversary Landmark Commentary on Bove EL, Behrendt DM

Alterations in coagulation after implantation of a pulsatile Novacor LVAD and the axial flow micromed DeBakey LVAD Andreas Koster, MD, Matthias Loebe,

Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device Roland Hetzer, MD, PhD, Johannes Müller, MD, Yuguo Weng,

CTSNet: a unique educational vehicle

Intrinsic cardiac stem cells are essential for regeneration

What is the marginal cost for marginal risk in cardiac surgery?

Implantation of a left ventricular assist device in situs inversus

Anomalous Great Cardiac Vein Draining Into the Superior Vena Cava

Victor van Berkel, MD, PhD

Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only Thierry P Carrel, MD, Mike Schwanda, MD,

Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass–induced injury Maurice Beghetti, MD, Philip E Silkoff, Marlova Caramori, MD,

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all David Faraoni, MD,

Pleural Metastasis of Osteosarcoma

Public policy and the practicing physician

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,

Who Do You Say You Are? The Annals of Thoracic Surgery

Analysis of the Risk Factors for Early Failure After Extracardiac Fontan Operation Stanislav Ovroutski, MD, Christian Sohn, MD, Payman Barikbin, MD, Oliver.

Detection of Lower Torso Ischemia by Near-Infrared Spectroscopy During Cardiopulmonary Bypass in a 6.8-Kg Infant With Complex Aortic Anatomy Mathias.

Heparin-induced thrombocytopenia and cardiac surgery

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Pediatric open heart operations without diagnostic cardiac catheterization Jean-Pierre Pfammatter, MD, Pascal A Berdat, MD, Thierry P Carrel, MD, Franco.

Foreign Bodies in the Esophagus

Oliver Miera, MD, Evgenij V

Michael J. Wolf, MD, Kirk R. Kanter, MD, Paul M. Kirshbom, MD, Brian E

Infant cardiopulmonary bypass: a procoagulant state

The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice.

Editorial Board, January 2010

Bradford B. Smith, MD, Matthew A

Sarah C. Huen, MD, Chirag R. Parikh, MD, PhD

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery Julio C Vasquez, MD, Anna Vichiendilokkul, PharmD, Syed Mahmood, MD,

Platelet and Neutrophil Activation During Cardiac Surgical Procedures: Impact of Cardiopulmonary Bypass David S Morse, David Adams, Barbarajean Magnani

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

A. Thomas Pezzella, MD, Sari D

Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery Karl F. Welke, MD, Mitchell J. Barnett, PharmD,

Anirudh Vinnakota, MS, Robert Stewart, MD, Gosta Pettersson, MD, PhD

Time course of proinflammatory and anti-inflammatory responses after cardiac operation: monocyte HLA-DR expression Y.John Gu, MD, PhD, Willem van Oeveren,

Simplified technique for implantation of a left ventricular assist system after previous cardiac operations Miralem Pasic, MD, PhD, Peter Bergs, MD,

Transabdominal endoscopic computer-enhanced coronary artery bypass grafting Volkmar Falk, MD, Frederic H Moll, MD, David J Rosa, Dave Daunt, DVM, Anno.

Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F

Use of polytetrafluoroethylene vascular graft to cover the kinking protector of left ventricular assist device facilitates later pump exchange Evgenij.

Aprotinin Enhances the Endogenous Release of Interleukin-10 After Cardiac Operations Gary E Hill, Robert P Diego, Alfred H Stammers, Suzanne M Huffman,

Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?

The future of cardiac surgery training: A survival guide

Neal S Goldstein, MD The Annals of Thoracic Surgery

Minimally invasive direct coronary artery bypass in a cardiac transplant recipient with allograft vasculopathy Ivan Aleksic, MD, PhD, Jarowit A Piotrowski,

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

Coronary bypass flow during use of intraaortic balloon pumping and left ventricular assist device Takeo Tedoriya, MD, Michio Kawasuji, MD, Naoki Sakakibara,

Short-term neuropsychologic differences after normothermic versus hypothermic cardiopulmonary bypass Dagmar Buschbeck, Friedrich-Christian Riess, MD,

Endothelial Cell Injury in Cardiovascular Surgery

Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

Sunjay Kaushal, MD, PhD, Brody Wehman, MD

The Annals of Thoracic Surgery

Late Consequences of a Much Earlier Decision

An Assay to Monitor Bivalirudin Levels on Cardiopulmonary Bypass

The Impact of New Technology on Cardiothoracic Surgical Practice

Bloodless Surgery of Acute Type A Aortic Dissection in a Jehovah’s Witness Patient Miralem Pasic, MD, PhD, Wolfgang Ruisz, MD, Andreas Koster, MD, PhD,

Safety of low hematocrits during cardiopulmonary bypass

Recombinant hirudin for extended aortic surgery in patients with heparin-induced thrombocytopenia Matthias Bauer, MD, Andreas Koster, MD, Miralem Pasic,

Repair of Left Ventricular Inflow Tract Lesions in Shone's Anomaly: Valve Growth and Long-Term Outcome Eva Maria B. Delmo Walter, MD, PhD, Richard Van.

Body Mass Index and Outcome After Ventricular Assist Device Placement

Presentation transcript:

Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control study Evgenij V Potapov, MD, Heinz R Zurbrügg, MD, PhD, Corinna Herzke, MD, Stefanie Srock, MD, Hanno Riess, MD, PhD, Ralf Sodian, MD, Sabine Hübler, MD, Roland Hetzer, MD, PhD The Annals of Thoracic Surgery Volume 74, Issue 2, Pages (August 2002) DOI: /S (02)

Fig 1 The Annals of Thoracic Surgery , DOI: ( /S (02) )

Fig 2 The Annals of Thoracic Surgery , DOI: ( /S (02) )